Forty Seven
Latest round
- Series B
Last raised
- Oct 2017
Total raised
- $150M
Investors
- 5
About Forty Seven
Forty Seven, Inc. is a biopharmaceutical company focused on advancing novel immunotherapies for treating cancer.Founded in 2015, Forty Seven, Inc. is based in Menlo Park, US. The company specializes in developing immunotherapies aimed at cancer treatment.Forty Seven, Inc. focuses on developing innovative immunotherapy treatments for cancer patients.In the most recent year available, Forty Seven, Inc.Forty Seven, Inc. aims to enhance its product portfolio by launching new immunotherapy treatments designed for specific cancer types, with detailed timelines yet to be announced. The company is also targeting expansion into international markets in Europe and Asia by 2025.
Who invested in Forty Seven
5 investors across 2 rounds
See all investors in Forty Seven
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Forty Seven
Who invested in Forty Seven?
Forty Seven has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Forty Seven raised?
Forty Seven has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Forty Seven last raise money?
Forty Seven's most recent round on record is a Series B, in Oct 2017.
What does Forty Seven do?
Forty Seven is a biotechnology company.
Where is Forty Seven headquartered?
Forty Seven is headquartered in Menlo Park, US.
Which VCs invest in companies like Forty Seven?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Forty Seven's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Forty Seven? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.